Meclizine Hydrochloride Tablet
NDC 63187-258
Product Information
Meclizine Hydrochloride is a ANDA-approved product labeled by Proficient Rx Lp. This medication is typically used as a antiemetic [epc]. It is supplied as a white tablet for oral administration. This product entry covers the primary NDC 63187-258 and 5 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
E14
Code Structure Chart
Product Details
What is NDC 63187-258?
What are the uses of this product?
What are Active Ingredients of this product?
- MECLIZINE HYDROCHLORIDE 25 mg/1 - A histamine H1 antagonist used in the treatment of motion sickness, vertigo, and nausea during pregnancy and radiation sickness.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- MECLIZINE HYDROCHLORIDE (UNII: HDP7W44CIO)
- MECLIZINE (UNII: 3L5TQ84570) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 995666 - meclizine HCl 25 MG Oral Tablet
- RxCUI: 995666 - meclizine hydrochloride 25 MG Oral Tablet
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.
Patient Education
Meclizine
Meclizine is used to prevent and treat nausea, vomiting, and dizziness caused by motion sickness. It is most effective if taken before symptoms appear.
[Learn More]
* Please review the full disclaimer at the bottom of this page.